leadf
logo-loader
viewBioLargo, Inc.

BioLargo's water technologies closer to commercialization, reports record 3Q

BioLargo, Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive its 3Q financial results saw its revenue rise 26% year-over-year to a record $0.67 million. Calvert says the group is ramping up several of its water technologies to prepare for commercialization including the AOS and the AEC, which he says will lead to first sales.

What's more, its industrial operating divisions each have a backlog of revenue-generating projects that collectively exceed $2 million, which it says will provide “reliable revenue” into 2021.

Quick facts: BioLargo, Inc.

Price: 0.14295 USD

OTCMKTS:BLGO
Market: OTCQB
Market Cap: $31.79 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioLargo, Inc. named herein, including the promotion by the Company of BioLargo, Inc. in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

BioLargo awarded contract at major chemical manufacturing plant for...

BioLargo (OTCQB: BLGO) CEO Dennis Calvert joined Steve Darling from Proactive Vancouver with news the company’s subsidiary BioLargo Engineering, Science & Technologies has been awarded a contract to assist in the reconfiguration of the Regenerative Thermal Oxidizer systems used at a large...

on 10/23/2020

2 min read